>>> Potential Sovereign rating after European close

Potential Sovereign rating after European close 
- (PT) Portugal Sovereign Debt Rating published by S&P 
- (FI) Finland Sovereign Debt Rating published by Fitch 
- (TR) Turkey Sovereign Debt Rating published by Fitch 
- (HU) Hungary Sovereign Debt to be rated by S&P 
- (NG) Nigeria Sovereign Debt to be rated by S&P 
- (FR) France Sovereign Debt might be published by Moody's 
- (SI) Slovenia Sovereign Debt Rating might be published by Moody's 
- (UK) UK Sovereign Debt Rating might be published by Moody's

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance: ADBE -2.2%

Select fan favs trading lower: NFLX -1.7%, GPRO -1.4%, FIT -1.2%, TSLA -1.2%, AAPL -0.9%, TWTR -0.9%, FB -0.8%

Select financial related names showing weakness: DB -2.6%, ING -2.5%, CS -2.2%, RBS -1.7%, HSBC -1.5%, SAN -1.4%, BCS -1.2%, WFC -0.9%

Select EU names stocks trading lower: TEF -2.7%, CRH -1.8%, SAP -1.6%, RCL -1.4%, GSK -1.4%, ABB -1.2%

Select oil/gas related names showing early weakness: PE -8.4%, WLL -2.6%, TOT -2.4%, SDRL -1.9%, RDS.A -1.8%

Other news: LQ -10.5% (revising its 2015 financial guidance as a result of weaker than anticipated hotel demand ; announces that President and CEO Wayne Goldberg has stepped down; accelerates its share repurchase program; approves a program to repurchase up to $100 million of its common stock, effective immediately ), BUD -2.4% (pulling back after recent strength), AI-1.9% (reduced its quarterly dividend to $0.625/share from $0.875/share), ITCI -1.7% (following 10 pt move higher yesterday), MTGE -1.1% (lowers quarterly dividend to $0.40/share from $0.50/share, says it repurchased 1.2 mln shares in Q3 )

Analyst comments: LXRX -4.6% (downgraded to Sell at Gabelli & Co), SFY -4.5% (downgraded to Sector Perform at RBC Capital Mkts)

>>> Amadeus - Competition and Markets Authority (CMA) has asked the European Com

Competition and Markets Authority (CMA) has asked the European Commission to investigate the merger of two providers of airline passenger service systems 

Amadeus and Navitaire both supply IT solutions, including passenger service systems, to airlines and other customers in the UK, Europe and across the world. Amadeus IT Group S.A. plans to acquire the information technology solutions, including the passenger service systems, business of Navitaire LLC.

The proposed acquisition qualifies for investigation by multiple EU Member States, including the UK, and the Competition and Markets Authority believes that in this instance it would be appropriate for the EC to undertake a single investigation on behalf of those Member States that wish to transfer jurisdiction to it.

Such a step is procedural and does not prejudge the EC's ability to determine, if it accepts jurisdiction, whether competition concerns arise in the UK as a result of the merger.

Other EU Member States have 15 working days from receipt of the CMA's request to determine whether to join the request. The Commission then has 10 working days in which to notify the CMA whether it has accepted jurisdiction in this case.

The CMA will publish on its website a non-confidential version of its request in due course.

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: PDEX +14.1%, AKS +8.2%, ZAYO +2.8%, KUTV +2.7%


Other news: SFXE +19.7% (cont strenght after co secured $60 mln in new financing and refinances its existing $30 mln revolving credit facility yesterday), VBLT +15.7% (announces that complete Phase 2 data on VB-111, in combination with Bevacizumab will be presented at the European Society for Medical Oncology's (ESMO) European Cancer Congress ), MTL +4.9% (still checking), SFUN +4.3% (announces a $400 to $700 mln investment from IDG, Carlyle and management members), RXDX +1.5% (announces initiation of Phase 1/1b clinical trial of RXDX-107 in patients with locally advanced or metastatic solid tumors ), KGC +1.2% (lowered guidance for all-in sustaining cost per gold equivalent ounce sold to $975-1025 from $1000-1100; lowers CapEx guidance to $650 mln from $725 mln), ARW +0.7% (announced authorization for an additional $400 million in repurchases, via its common share repurchase program)

Analyst comments: CEMP +3.6% (announces the FDA has granted qualified infectious disease product designation to Taksta), GSBD +0.7% (upgraded to Outperform from Mkt Perform at Raymond James)